Semaglutide 15mg — Vial Spec, Reconstitution Math & COA

Overview of the 15mg Semaglutide Research Specification

The 15mg semaglutide vial format is engineered for high-volume laboratory applications where maintaining consistent lot uniformity across multiple experimental assays is essential. In preclinical settings, larger mass fills allow investigative teams to perform broad concentration-gradient studies or multi-animal cohort dosing from a single, standardized lot mass without introducing inter-vial variance.

A 15mg vial contains 15 milligrams of purified, lyophilized semaglutide peptide cake alongside a protective bulking agent (typically mannitol or trehalose) designed to stabilize tertiary structure during freeze-drying. Note on current inventory: PX1 Research primary catalog configurations frequently center on standard assay-sized units (such as 2mg, 3mg, or 5mg vials) to minimize moisture exposure during routine reconstitution. If the specific 15mg single-vial packaging is not currently active on our store, researchers can review identical high-purity batch runs across our complete /all-peptides catalog or coordinate custom high-mass fills via our /wholesale laboratory account portal.

Molecular Structure & Preclinical Target Identification

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist featuring a sequence engineered to resist enzymatic cleavage by dipeptidyl peptidase-4 (DPP-4). Its primary chemical structure is based on human GLP-1(7-37) with two key structural modifications: an amino acid substitution of alpha-aminobutyric acid (Aib) at position 8 to prevent DPP-4 degradation, and a lysine substitution at position 26 attached via a glutamic acid spacer to a C18 fatty diacid chain. The chemical formula for the free base is C187H291N45O59, with a nominal molecular weight of approximately 4113.58 Da.

In vitro functional assays demonstrate that semaglutide selectively binds to and activates human GLP-1 receptors with sub-nanomolar affinity, stimulating intracellular cyclic adenosine monophosphate (cAMP) accumulation. The hydrophobic acylation facilitates reversible binding to serum albumin, which drastically retards renal clearance in animal models and extends the terminal elimination half-life during pharmacodynamic studies.

Reconstitution Math: Calculating Concentrations for a 15mg Lyophilized Mass

Reconstituting a high-mass 15mg cake requires precise volumetric calculations to achieve target molarities or working microgram-per-microliter (µg/µL) concentrations. When introducing diluent—such as 0.9% Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Normal Saline—researchers should account for the displacement volume of the lyophilized solid, which adds approximately 0.01–0.02 mL per 10mg of cake.

Below are standard laboratory reconstitution parameters for a 15mg semaglutide vial across common diluent addition volumes:

1.0 mL Diluent Addition: Yields a final working concentration of approximately 15.0 mg/mL (15.0 µg/µL or 15,000 µg/mL). This high concentration is ideal for low-volume micro-injections in microfluidic assays or high-density stock solutions.

2.0 mL Diluent Addition: Yields a final working concentration of 7.5 mg/mL (7.5 µg/µL or 7,500 µg/mL). This moderate concentration balances liquid handling accuracy with minimal syringe volume dead-space loss.

3.0 mL Diluent Addition: Yields a final working concentration of 5.0 mg/mL (5.0 µg/µL or 5,000 µg/mL). This dilution is suited for automated liquid handling workstations performing multi-well plate titrations.

To quickly recalculate custom volumetric dilutions or target molar concentrations for specific assay wells, researchers can utilize the online /reconstitution-calculator tool provided in our technical hub.

Aliquot Planning & In Vitro Handling Protocols

Because reconstituting a 15mg cake results in a substantial volume of active research solution, executing a formal aliquot plan immediately after dissolution is mandatory to prevent degradation caused by repeated freeze-thaw cycles. Liquid peptide solutions subjected to multiple temperature fluctuations suffer from peptide aggregation, peptide chain cleavage, and loss of biological activity.

Upon full dissolution (achieved through gentle swirling without vigorous vortexing), the stock solution should be aliquoted into sterile, polypropylene low-binding microcentrifuge tubes in single-use assay volumes (e.g., 50 µL to 200 µL). Aliquots intended for use within 7 to 14 days may be maintained at 2°C to 8°C. Sub-aliquots reserved for extended timeline studies must be stored at -20°C or -80°C until the precise time of assay execution.

Quality Verification: Lot-Matched COA and Analytical Integrity

High-mass research peptides demand rigorous quality verification due to the concentration of material in a single vial. PX1 Research subjects every synthesis batch to strict analytical verification in an ISO 17025 accredited laboratory, regardless of total unit volume.

Each batch of semaglutide undergoes High-Performance Liquid Chromatography (HPLC) to establish chemical purity, ensuring every lot meets or exceeds our strict ≥98.0% target purity threshold. Mass Spectrometry (MS) analysis is conducted concurrently to verify the exact molecular mass against the theoretical target (4113.6 Da), confirming the absence of truncated sequences or incomplete acylation variants. Furthermore, bacterial endotoxin testing via the Chromogenic LAL method ensures that endotoxin levels remain strictly below <0.01 EU/µg. Researchers can independently inspect batch analytical reports for their active lot directly on our /coa verification portal.

Comparative Analysis: Semaglutide vs. Related Incretin Analogs

When evaluating metabolic pathway signalling, laboratory researchers frequently compare single GLP-1 receptor agonists like semaglutide against multi-receptor incretin mimetics and co-agonists. Understanding structural and receptor binding differences aids in selecting the appropriate reference compound for specific in vitro assays.

While semaglutide maintains selective mono-agonism at the GLP-1 receptor, dual GIP/GLP-1 analogs such as /research-peptides/tirzepatide-reconstitution-guide exhibit dual agonism that influences downstream lipolytic and glycemic signaling differently in adipocyte and pancreatic beta-cell models. Similarly, triple agonists target GLP-1, GIP, and Glucagon receptors concurrently, whereas specialized receptor ligands like /product/glp2-t explore selective GI tract mucosal cell proliferation via GLP-2 pathways. Comprehensive comparative data across these related classes can be reviewed in our technical hub for /research-peptides/glp1-receptor-agonists.

Storage, Stability & Buffer Compatibility Guidelines

Lyophilized semaglutide 15mg vials must be stored in a temperature-controlled freezer environment at -20°C to -80°C upon receipt. Under these sub-zero, desiccated conditions, the unconstituted peptide maintains chemical stability and structural integrity for up to 24 months from the manufacturing date.

Reconstituted solutions require careful handling regarding pH and buffer selection. Semaglutide demonstrates maximum solubility and physical stability in neutral to slightly alkaline buffers (pH 7.4–8.0). Exposure to acidic conditions (pH < 5.0) can induce precipitation due to the isoelectric point properties of the acylated peptide sequence. When diluting into cell culture media, ensure proper buffering with HEPES or phosphate-buffered saline (PBS) to avoid localized micro-environment pH drops.

Vial Size Selection: Determining When a 15mg Mass vs. Standard Yield is Optimal

Selecting the correct fill mass depends entirely on the design, duration, and volume requirements of the research project. While a 15mg format minimizes container-closure overhead and batch-to-batch variation across large study cohorts, smaller vial formats (such as 2mg or 5mg) offer distinct advantages for exploratory or low-throughput laboratory setups.

A 15mg vial is the optimal choice when running automated liquid handling systems, high-density 384-well microplate assays, or continuous multi-week animal study protocols where a single lot batch must be shared across parallel trial arms. Conversely, for short-duration assays or initial feasibility trials, lower-mass vials reduce the risk of solution degradation or waste from leftover reconstituted material. Researchers requiring bulk quantities for custom project scales are encouraged to consult our /wholesale department to discuss tailor-made synthesis and lot sizing.